Salmeterol ticarcoson inhaler, a medication used to treat asthma and chronic obstructive pulmonary disease in children or adults, is for inhalation use. It contains two ingredients, salmeterol and fluticasone propionate. Salmeterol is a beta 2 agonist that dilates the airways, relieves airway spasm, and reduces wheezing in asthma and COPD. Fluticasone propionate is an inhaled hormone whose main action is to reduce the inflammatory response in the airways and decrease airway hyperresponsiveness. Salmeterol ticarcoson inhaler can be used in the routine treatment of reversible obstructive airway disease, including asthma in adults and children and in patients with chronic obstructive pulmonary disease, to act as an anti-inflammatory and airway dilator. It is administered by inhalation, and possible adverse reactions include tremor, palpitations, headache, oral candida infections, and in some patients, cardiac arrhythmias and skin rashes. It is contraindicated for those who are allergic to any of the components of the product, and you need to rinse your mouth promptly after use to prevent oral candida infections. The above drugs need to be standardized and rationally applied under the guidance of professional physicians and pharmacists. If the symptoms fail to improve or even gradually worsen, it is necessary to consult a regular hospital in a timely manner and cooperate with the doctor to improve the examination and standardize the treatment.